48 completed, 18 terminated, 14 unknown, 10 not yet recruiting. 55 Not applicable, 20 Phase 2, 9 Phase 3, 6 Phase 1, 2 Early Phase 1.
Follow Institut Cancerologie de l'Ouest: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of ATO-101™ in Patients With Non-Muscle-Invasive Bladder Cancer (PERSEVERANCE EU) ATO-101™ - Bladder Cancer | Phase 1 | Not yet recruiting | Institut Cancerologie de l'Ouest | 24 | 2027-01-01 | 2026-06-08 |
| Bacterial Decolonization to Prevent Severe Radiation Dermatitis in Head and Neck Squamous Cell Carcinoma Bacterial decolonization, Standard Hygiene Measures - HNSCC | Not applicable | Not yet recruiting | Institut Cancerologie de l'Ouest | 144 | 2027-01-01 | 2026-10-22 |
| An Overview of Vaccination Coverage Among Patients Receiving Treatment for Breast Cancer at the ICO: Identifying Factors Associated With Vaccination Uptake and Improved Prevention questionnaire on vaccination status - Breast Cancer | Not yet recruiting | Institut Cancerologie de l'Ouest | 312 | 2026-10-12 | 2026-10-22 | |
| Stereotactic Radiotherapy for SPinal Metastases With Limited Extent of Epidural Disease Stereotactic Body Radiotherapy (SBRT), Conventional External Beam Radiotherapy - Epiduritis, Vertebral Bone Metastasis | Not applicable | Not yet recruiting | Institut Cancerologie de l'Ouest | 167 | 2026-10-01 | 2026-06-18 |
| Evaluation of the Value of [68Ga]Ga-PENTIXAFOR PET-CT in Patients With Metastatic Small Cell Lung Cancer (SCLC) [68Ga]Ga-PentixaFor - Small Cell Lung Carcinoma (SCLC) | Early Phase 1 | Not yet recruiting | Institut Cancerologie de l'Ouest | 15 | 2026-09-30 | 2026-06-18 |
| Efficacy of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) in Aromatase Inhibitor-induced Arthralgia (AIA) Active taVNS (TENS ECO Plus), Sham taVNS (TENS ECO Plus) - Breast Cancer, Aromatase Inhibitor-induced Arthralgia | Not applicable | Not yet recruiting | Institut Cancerologie de l'Ouest | 60 | 2026-09-01 | 2026-05-22 |
| HIghly MetAstatic Life Prolonging Therapy-Resistant Prostate Cancer: Role of Stereotactic Radiotherapy for Bone and Lymph Node Metastases (HIMARS) Stereotactic body radiotherapy (SBRT) - Prostate Cancer Metastatic Disease, Oligometastatic Prostate Cancer (OMPC) | Not applicable | Recruiting | Institut Cancerologie de l'Ouest | 18 | 2026-06-01 | 2026-06-04 |
| Clinical and Biological Study of Early-onset Breast Cancer and the Influence of the Reproductive Cycle on the Aggressiveness of the Disease No Intervention: Observational Cohort - Breast Cancer | Not yet recruiting | Institut Cancerologie de l'Ouest | 1000 | 2026-05-01 | 2026-05-22 | |
| Feasibility Study of Urinary cfDNA Analysis as a Non-invasive Monitoring Tool in Patients With Prostate or Bladder Cancer Prostate Cancer, Bladder Cancer | Not yet recruiting | Institut Cancerologie de l'Ouest | 25 | 2026-05-01 | 2026-03-16 | |
| Study Evaluating the Combination of Bemarituzumab + FLOT Chemotherapy in Perioperative Setting for Resectable Stage cT2-T4a or N+ Gastric and GEJ Adenocarcinoma Overexpressing FGFR2b Bemarituzumab + Flot regimen - Gastric and Gastro-oesophageal Junction (GEJ) Adenocarcinomas, Overexpression FGFR2b | Phase 2 | Withdrawn | Institut Cancerologie de l'Ouest | 2026-01-01 | 2026-01-21 | |
| Assessement of Potential Interest of [68Ga]Ga-PentixaFor PET/CT in Metastatic Triple Negative Breast Cancer Patients [68Ga]Ga-PentixaFor PET/CT - Metastatic Breast Cancer | Not applicable | Recruiting | Institut Cancerologie de l'Ouest | 12 | 2025-12-05 | 2026-01-12 |
| Reproductive Health in Breast Cancer Survivor Breast Cancer | Active not recruiting | Institut Cancerologie de l'Ouest | 22000 | 2025-12-01 | 2026-02-17 | |
| Impact of the MRI Restraint System on the Quality of the Synthetic Scan for Intracranial Radiotherapy Treatment MRI without mask, MRI with mask 1, MRI with mask 2 - Device Ineffective | Not applicable | Completed | Institut Cancerologie de l'Ouest | 3 | 2025-05-19 | 2026-03-10 |
| To Assess the Contribution of Sophrology Assisted by an Ambulatory Device on the Anxiety of Patients Undergoing Chemotherapy for the Treatment of Localized Breast Cancer sophrology sessions, Morphee Device - Breast Cancer Female | Not applicable | Recruiting | Institut Cancerologie de l'Ouest | 63 | 2025-05-15 | 2025-06-29 |
| Corticodependent or Corticoresistant Brain Radionecrosis After Radiotherapy for Brain Metastases Bevacizumab, Placebo, Prednisolone - Radionecrosis of Brain, Brain Metastases | Phase 3 | Recruiting | Institut Cancerologie de l'Ouest | 84 | 2025-04-29 | 2025-08-17 |
| Systemic Antitumor Treatment with or Without Pressurized Intraperitoneal Aerosol Chemotherapy for Colon Peritoneal Metastases (PIPOX02) Standard Medical Therapy, PIPAC - Peritoneal Metastases from Colorectal Cancer | Phase 2 | Not yet recruiting | Institut Cancerologie de l'Ouest | 114 | 2025-02-01 | 2024-11-08 |
| Evaluation of the Efficiency of Touch Massage on the Quality of Life at Work of Nursing Staff Working in a Cancer Center. (Pause "Toucher Massage (TM)") Touch Massage - Quality of Life at Work, Paramedical Professionals | Not applicable | Active not recruiting | Institut Cancerologie de l'Ouest | 88 | 2024-05-16 | 2025-04-15 |
| Socioeconomic Determinants of the Chemical Exposome and Its Genotoxic Effects in Children Hair cut, Socio-economic questionnaires - Healthy Volunteer Children | Not applicable | Completed | Institut Cancerologie de l'Ouest | 149 | 2024-01-29 | 2026-05-22 |
| Prediction in Silico of Pathological Response in a Prospective Cohort Study of Early Breast Cancer Patients Biopsy, Blood samples, Questionnaires - Breast Cancer | Not applicable | Recruiting | Institut Cancerologie de l'Ouest | 300 | 2023-10-31 | 2026-03-31 |
| Capsaicin 179 mg Patch Versus Oral Duloxetine in Patients With Chemotherapy-induced Peripheral Neuropathy Capsaicin, Duloxetine - Chemotherapy-induced Peripheral Neuropathy | Phase 3 | Recruiting | Institut Cancerologie de l'Ouest | 274 | 2023-10-20 | 2026-03-31 |
Showing 20 of 112. Sign in to see all of them.
Breast Neoplasms (30) · Neoplasms (8) · Prostatic Neoplasms (8) · Rectal Neoplasms (7) · Colorectal Neoplasms (6) · Neoplasm Metastasis (6) · Anxiety Disorders (4) · Brain Neoplasms (4) · Colonic Neoplasms (4) · Melanoma (4) · Head and Neck Neoplasms (3) · Lung Neoplasms (3) · Triple Negative Breast Neoplasms (3) · Urinary Bladder Neoplasms (3) · Adenocarcinoma (2)
Fluorouracil (5) · Leucovorin (5) · Oxaliplatin (4) · Radiosurgery (4) · Cetuximab (3) · Irinotecan (3) · Biopsy (2) · Blood Specimen Collection (2) · Capsaicin (2) · Mammaplasty (2) · Pharmacogenomic Testing (2) · Quality of Life (2) · Radiation (2) · Radiotherapy (2) · Radiotherapy, Intensity-Modulated (2)
France (108) · Germany (1) · Spain (1)
Erick Gamelin, MD (2) · Olivier Capitain, MD, PhD (2)
PMID 15683820, PMID 18797458, PMID 22520742, PMID 25963190, PMID 26408012, PMID 26615857, PMID 27214241, PMID 30911664, PMID 31118057, PMID 31331370, PMID 31421657, PMID 31833973, PMID 33039812, PMID 33789635, PMID 34996593, PMID 35380718, PMID 37442917, PMID 40707156, PMID 41174094, PMID 42140755, PMID 42189020, PMID 42276876, PMID 8892467
2008 (3), 2014 (1)